Scientist II with expertise in CRISPR screening and macrophage differentiation at Tango Therapeutics. Developed innovative platforms and mentored junior scientists. Proficient in flow cytometry and data interpretation, with strong communication skills. Created macrophage phagocytosis platform, advancing novel cancer targets.
Examined the regulation of Notch1 in differentiated T cells by inhibiting PKCq function
Tested the hypothesis that FANCJ coordinates effective DNA repair processing and inhibits competing pathways
October 2022 Lei Ji, Grace Trombley, Alyssa Agarwal, Wenrong Zhou, Serge Gueroussov, Henry Weith, Sophia Paxton, Ashley Choi, Tenzing Khendu, Samuel Meier, Shangtao Liu, Binzhang Shen, Teng Teng, Yi Yu, Xuewen Pan, Alan Huang, Chengyin Min “Leveraging CRISPR-Cas9 screening platform for discovery of novel tumor intrinsic phagocytosis modulators.” Society for Immunotherapy of Cancer, Boston, MA
May 2016 Grace Trombley, E. Ilker Ozay, Lisa M. Minter. “Exploring the
Influence of PKCθ V3 domain and Thr538 Phosphorylation in
CD4+ T Cell Function.” Undergraduate Research Conference,
Amherst, MA
August 2015 Grace Trombley, Sumeet Nayak, Sharon Cantor. “FANCJ at the FORK.” American Cancer Society, Framingham, MA.
May 2015 Grace Trombley, E. Ilker Ozay, Pavitra Chikkegowda, Lisa M. Minter. “Exploring the PKCθ-CD69 Regulatory Axis.” Undergraduate Life Sciences Symposium, Amherst, MA